HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Alpha Tau Medical (NASDAQ:DRTS) and maintained a $9 price target.

March 12, 2024 | 4:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Alpha Tau Medical's stock rating was reiterated as Buy by HC Wainwright & Co. with a maintained price target of $9.
The reiteration of a Buy rating and a maintained price target by a reputable analyst like Yi Chen from HC Wainwright & Co. is likely to instill confidence among investors and could lead to a positive short term impact on Alpha Tau Medical's stock price. Analyst ratings, especially from well-regarded firms, often influence investor perception and can lead to price movements.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100